GL

Greg Langley

Chief Technology Officer

Aktiv Pharma Group

Denver, Colorado


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Aktiv Pharma Group
Industry
pharmaceuticals
Employees
29.0
Seniority
C suite
Annual Revenue
10300000.0

Technologies

Outlook Typekit Mobile Friendly Squarespace ECommerce Remote Python AI

Keywords

autoinjectors specialty pharmaceuticals drug delivery devices hypoglycemia treatments emergency medicine opioid overdose treatments anaphylaxis treatments biotechnology life sciences pharmaceutical manufacturing drug delivery prefilled drug delivery systems arch container biopharmaceutical mrna vaccines therapeutics autoinjector technology dual-chamber configuration cost-efficient manufacturing self-administration commercial biopharma market cdmo device innovation gmp assembly sterile fill-finish high-barrier primary drug container pressurized gas injection modular autoinjector adjustable injection time controlled injection rate automatic needle retraction pre-filled syringes intranasa delivery iv transfer systems reducing drug wastage sustainability carbon footprint reduction high viscosity formulations reconstitution single-hand activation tactile feedback visual feedback fda reliability patent pending system gmp pilot manufacturing quality management system advanced machine shop drug formulation cleanroom operations r&d labs device development combination products equipment development clinical lot support leading biopharma collaborator innovative container closure agile development team pharmaceuticals medical environmental services renewables & environment

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans